# Spain Cardiopulmonary Exercise Testing Market > Spain Cardiopulmonary Exercise Testing Market Research Report By Product (CPET Metabolic Carts, Software) and By End User (Hospitals and amp; Clinics, Diagnostic Centers, Ambulatory Centers, Others) - Growth & Industry Forecast 2025 To 2035 - **Forecast Period:** 2025 - 2035 - **CAGR:** 7.33% - **2024:** $ 19.2 Million - **2025:** $ 20.61 Million - **2035:** $ 41.81 Million - **Key Players:** Cardinal Health (US), Philips (NL), GE Healthcare (US), Schiller AG (CH), MediSoft (FR), Cosmed (IT), KORR Medical Technologies (US), Bodystat (GB) **Report ID:** MRFR/HC/51058-HCR · **Pages:** 200 · **Author:** Rahul Gotadki · **Last Updated:** August 07, 2026 **URL:** https://www.marketresearchfuture.com/reports/spain-cardiopulmonary-exercise-testing-market-52819 --- ## Market Summary ## **Spain Cardiopulmonary Exercise Testing Market Overview** As per MRFR analysis, the Spain Cardiopulmonary Exercise Testing Market Size was estimated at 27 (USD Million) in 2023. The Spain Cardiopulmonary Exercise Testing Market Industry is expected to grow from 28.8(USD Million) in 2024 to 85.5 (USD Million) by 2035. The Spain Cardiopulmonary Exercise Testing Market CAGR (growth rate) is expected to be around 10.398% during the forecast period (2025 - 2035) ## **Key Spain Cardiopulmonary Exercise Testing Market Trends Highlighted** The Spain Cardiopulmonary Exercise Testing Market is witnessing significant trends driven by a growing emphasis on preventive healthcare and early diagnosis of cardiovascular diseases. The Spanish healthcare system is increasingly focused on improving patient outcomes through comprehensive testing and monitoring, which has stimulated demand for cardiopulmonary exercise testing (CPET). Furthermore, the rise in chronic respiratory diseases, coupled with an aging population, reinforces the necessity for effective diagnostic tools, making CPET an essential part of patient evaluation in clinical settings.  Moreover, technological advancements play a crucial role in shaping market trends, with a shift towards integrating digital health solutions that enhance the accuracy and efficiency of exercise testing.The development of portable and user-friendly CPET devices allows for greater accessibility and convenience in various healthcare environments, thus driving adoption rates. Opportunities in the Spanish market also include increased awareness about cardiopulmonary health among healthcare professionals and patients, leading to more frequent testing and consultations that incorporate CPET as a standard practice.  Recent trends indicate a collaborative approach among healthcare providers, research institutions, and technology developers in Spain, fostering innovations that improve testing protocols and patient care. The Spanish government has also been investing in research and development initiatives related to cardiovascular health, which should further boost market growth.All these factors point towards a promising future for the CPET market in Spain, as the focus remains on enhancing patient diagnostics and health management through advanced exercise testing methodologies. Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review ## **Spain Cardiopulmonary Exercise Testing Market Drivers** ### **Rising Prevalence of Cardiovascular Diseases** The rising frequency of cardiovascular disorders is a major driver of the Spain Cardiopulmonary Exercise Testing Market. According to data from the Spanish Heart Foundation, cardiovascular disorders account for almost 30% of all fatalities in Spain, showing a strong demand for diagnostic testing procedures. As the population ages and lifestyle-related health conditions become more prevalent, the demand for appropriate cardiovascular examination and surveillance will increase.  Hospitals and health organizations, such as the Clinical Hospital of Barcelona, are aggressively integrating these testing methods into routine assessments, which is likely to significantly increase market growth in the future years. ### **Growing Focus on Preventive Healthcare** In Spain, there is a marked shift towards preventive healthcare, which plays a critical role in the growth of the Spain Cardiopulmonary Exercise Testing Market Industry. The Spanish government has been promoting healthy lifestyle initiatives and regular health screenings to curb the rise of chronic health conditions. Recent public health campaigns indicate an overall increase of 15% in health check-up rates among adults over the past five years.  Facilities that provide cardiopulmonary exercise testing services report that they are experiencing heightened interest and participation from individuals seeking preventive assessments, which has been further supported by health professionals advocating for early diagnosis and intervention. ### **Technological Advancements in Diagnostic Equipment** The advancement of technology in diagnostic equipment has been a key factor driving the Spain Cardiopulmonary Exercise Testing Market Industry. Innovations such as portable testing devices and enhanced software applications for data analysis have made cardiopulmonary tests more accessible and efficient. For instance, Spanish companies like Quattrocento have developed sophisticated testing apparatus that caters to both clinical settings and mobile health solutions. The integration of artificial intelligence in test reporting allows for faster and more accurate results, leading to an increase in the adoption of these technologies by healthcare providers in Spain, thus driving market expansions. ## **Spain Cardiopulmonary Exercise Testing Market Segment Insights** ### **Cardiopulmonary Exercise Testing Market Product Insights** The Spain Cardiopulmonary Exercise Testing Market is comprised of various products designed to enhance the efficiency and accuracy of cardiopulmonary assessments. Within this realm, CPET Metabolic Carts play a crucial role, providing essential data on metabolic exchange, exercise capacity, and overall cardiovascular efficiency during exercise testing. These carts typically incorporate advanced technologies, which facilitate real-time monitoring and precise analysis, enabling healthcare providers to make informed decisions about patient care.  The significance of these metabolic carts is underscored by their ability to support physicians in diagnosing and managing cardiovascular diseases, pulmonary conditions, and various other health issues related to exercise tolerance.In addition, the software used in conjunction with CPET equipment contributes greatly to the usability and effectiveness of the testing process. This software aids in the collection, interpretation, and presentation of data, streamlining the workflow in clinical settings.  By offering comprehensive analysis tools, the software enhances the clinician's ability to interpret cardiopulmonary responses accurately, thus improving patient outcomes. As the demand for non-invasive testing methods increases within Spain's healthcare infrastructure, the integration of innovative software solutions becomes essential.  Overall, the product segment within the Spain Cardiopulmonary Exercise Testing Market illustrates the commitment to advancing cardiac health assessment technology, which aligns with national health goals aimed at reducing the burden of chronic diseases and enhancing the quality of healthcare delivery. Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review ### **Cardiopulmonary Exercise Testing Market End User Insights** The End User segment of the Spain Cardiopulmonary Exercise Testing Market showcases a diverse array of healthcare settings, including Hospitals and Clinics, Diagnostic Centers, Ambulatory Centers, and Others. Hospitals and Clinics are pivotal, contributing significantly to the overall market as they provide comprehensive care and have advanced infrastructure to facilitate cardiopulmonary exercise testing. Diagnostic Centers are also crucial as they enhance patient access to specialized testing and diagnostics, ultimately improving patient outcomes and streamlining healthcare processes. Ambulatory Centers have gained traction by offering flexibility and convenience for patients requiring outpatient services, thereby driving the demand for cardiopulmonary exercise testing. The Others category encompasses various healthcare facilities that contribute to market growth in unique ways, reflecting the increasing awareness of cardiopulmonary health. Overall, the segmentation underscores the increasing need for comprehensive cardiopulmonary testing solutions across multiple healthcare settings in Spain, driven by a rise in cardiovascular diseases and a growing emphasis on preventive healthcare strategies. This diverse landscape presents opportunities for innovation and growth in the Spain Cardiopulmonary Exercise Testing Market, aligning with broader healthcare trends. ## **Spain Cardiopulmonary Exercise Testing Market Key Players and Competitive Insights** The Spain Cardiopulmonary Exercise Testing Market has experienced notable growth, driven by an increasing emphasis on preventive healthcare and the rising prevalence of cardiovascular diseases among the population. With a focus on improving patient outcomes through enhanced diagnostic capabilities, various companies have emerged as key players in this field. The competitive landscape is characterized by the presence of established firms offering comprehensive solutions designed to facilitate effective testing and evaluation of cardiopulmonary function.  The interplay between regulatory factors, technological advancements, and shifting consumer preferences shapes the dynamics of this market, highlighting the importance of continuous innovation and strategic partnerships among the competitors.Siemens Healthineers has carved a significant niche in the Spain Cardiopulmonary Exercise Testing Market through its innovative product offerings and robust commitment to quality healthcare solutions. The company stands out with its advanced diagnostic equipment, which includes state-of-the-art cardiopulmonary exercise testing devices. Siemens Healthineers leverages its extensive experience and expertise to maintain a competitive edge, augmenting the accessibility and effectiveness of cardiopulmonary diagnostics.  The company’s strong market presence is bolstered by its collaboration with healthcare institutions, enabling better integration of its technologies into clinical practices. This collaborative approach not only enhances the utility of their products but also positions Siemens Healthineers as a trusted partner in the healthcare ecosystem in Spain. Schiller has also established a prominent footprint in the Spain Cardiopulmonary Exercise Testing Market, focusing on high-quality, innovative medical devices that cater to cardiology and pulmonary testing needs. The company offers a range of products, including exercise testing systems that are tailored for healthcare facilities in Spain, enhancing diagnostic accuracy and patient care.  Schiller's strengths lie in its commitment to continuous research and development, which fuels its ability to respond to emerging needs within the market. Additionally, the company has pursued strategic mergers and acquisitions to broaden its portfolio and operational capacity within the region. This strategy not only enhances Schiller's service offerings but also solidifies its position as a key player in the market, contributing to the advancement of cardiopulmonary testing and diagnostics in Spain. ### **Key Companies in the Spain Cardiopulmonary Exercise Testing Market Include** - Siemens Healthineers - Schiller - [**Cosmed**](https://www.cosmed.com/en/resources/science/95-cardio-pulmonary-exercise-test/) - CareFusion - Drager - MGC Diagnostics - General Electric - Parvo Medics - Philips - Fukuda Denshi - Vyaire Medical - KORR Medical Technologies - Welch Allyn - Cardinal Health - Bionet ## **Spain Cardiopulmonary Exercise Testing Market Industry Developments** Recent developments in the Spain Cardiopulmonary Exercise Testing Market have been marked by significant advancements and investments, particularly from key players such as Siemens Healthineers and Philips. In September 2023, a major collaborative initiative was announced between MGC Diagnostics and CareFusion to enhance the technological capabilities of cardiopulmonary testing in hospitals across Spain. The market has also seen a notable uptrend in valuation, driven by the increasing prevalence of respiratory and cardiovascular diseases, prompting healthcare providers to invest in advanced diagnostic equipment.  In the past two years, particularly in June 2022, General Electric expanded its product line within Spain to include innovative cardiopulmonary exercise testing solutions, emphasizing the importance of precision medicine in patient assessment. Moreover, Vyaire Medical received recognition for its latest advancements in exercise testing technologies in early 2023, reflecting the growing emphasis on quality of care in cardiology. As these companies continue to innovate, the demand for sophisticated testing solutions remains robust, thereby influencing the overall market trajectory in Spain. However, no recent mergers or acquisitions have been prominently reported in this sector within the specified companies. ## **Spain Cardiopulmonary Exercise Testing Market Segmentation Insights** ### **Cardiopulmonary Exercise Testing Market Product****Outlook** - CPET Metabolic Carts - Software ### **Cardiopulmonary Exercise Testing Market End User****Outlook** - Hospitals & Clinics - Diagnostic Centers - Ambulatory Centers - Others ## Market Drivers ### Growing Aging Population The increasing aging population in Spain is a pivotal driver for the cardiopulmonary exercise-testing market. As individuals age, they often experience a decline in cardiovascular and pulmonary function, necessitating regular assessments to monitor health. According to recent statistics, approximately 19% of Spain's population is over 65 years old, a figure projected to rise. This demographic shift is likely to escalate the demand for cardiopulmonary exercise testing, as healthcare providers seek to implement preventive measures and manage chronic conditions effectively. Furthermore, the Spanish healthcare system is adapting to cater to this aging demographic, which may lead to increased funding and resources allocated to cardiopulmonary health assessments. Consequently, the cardiopulmonary exercise-testing market is expected to expand significantly, driven by the need for tailored health solutions for older adults. ### Increased Health Awareness There is a notable rise in health awareness among the Spanish population, which is driving the cardiopulmonary exercise-testing market. As individuals become more conscious of their health and fitness, there is a growing demand for preventive health measures, including regular cardiopulmonary assessments. Public health campaigns and educational programs have contributed to this trend, encouraging people to prioritize their cardiovascular and pulmonary health. This heightened awareness is likely to lead to increased referrals for exercise testing from primary care physicians and specialists. Consequently, healthcare providers may expand their cardiopulmonary testing services to meet this demand, thereby fostering growth in the market. The emphasis on preventive health is expected to remain a key driver in the coming years. ### Supportive Regulatory Environment The regulatory landscape in Spain is becoming increasingly supportive of the cardiopulmonary exercise-testing market. The Spanish government has implemented policies aimed at improving healthcare access and quality, which includes promoting diagnostic testing for cardiovascular and pulmonary conditions. Regulatory bodies are likely to streamline the approval processes for new testing technologies and methodologies, facilitating market entry for innovative solutions. Additionally, funding initiatives aimed at enhancing healthcare infrastructure may provide further impetus for the adoption of cardiopulmonary exercise testing. As a result, the cardiopulmonary exercise-testing market is expected to benefit from a favorable regulatory environment, encouraging investment and development in this sector. ### Advancements in Medical Technology Technological innovations in medical devices and testing methodologies are significantly impacting the cardiopulmonary exercise-testing market. In Spain, the integration of advanced technologies such as telemedicine and wearable fitness trackers is transforming how cardiopulmonary assessments are conducted. These advancements facilitate remote monitoring and real-time data analysis, making it easier for healthcare providers to evaluate patients' cardiopulmonary health. Moreover, the introduction of more sophisticated exercise testing equipment enhances the accuracy and efficiency of assessments. As healthcare facilities increasingly adopt these technologies, the cardiopulmonary exercise-testing market is poised for growth. The Spanish government is also likely to support these innovations through funding and research initiatives, further propelling the market forward. ### Rising Incidence of Cardiovascular Diseases The prevalence of cardiovascular diseases (CVD) in Spain is a critical factor influencing the cardiopulmonary exercise-testing market. Reports indicate that CVD accounts for nearly 30% of all deaths in the country, underscoring the urgent need for effective diagnostic and monitoring tools. Cardiopulmonary exercise testing serves as a valuable method for evaluating cardiovascular health, enabling healthcare professionals to identify risk factors and tailor treatment plans. The Spanish government has recognized this issue, implementing various health initiatives aimed at reducing CVD rates, which may further stimulate the demand for exercise testing. As awareness of cardiovascular health continues to grow, the cardiopulmonary exercise-testing market is likely to see increased adoption among healthcare facilities, thereby enhancing patient outcomes and driving market growth. ## Future Outlook The [Cardiopulmonary Exercise Testing Market](https://www.marketresearchfuture.com/reports/cardiopulmonary-exercise-testing-market-6626) in Spain is projected to grow at a 7.33% CAGR from 2025 to 2035, driven by technological advancements and increasing health awareness. **New opportunities:** - Development of portable exercise testing devices for home use. - Integration of AI analytics for personalized exercise prescriptions. - Expansion of telehealth services for remote cardiopulmonary assessments. By 2035, the market is expected to achieve substantial growth, reflecting evolving healthcare demands. ## Segment Insights ### By Product Type: CPET metabolic carts (Largest) vs. software (Fastest-Growing) The CPET metabolic carts represent the largest segment within the Spain cardiopulmonary exercise-testing market, capturing a significant share due to their advanced features and reliability in clinical settings. In contrast, software solutions are gaining traction, driven by the increasing integration of technology in health assessments and the growing demand for data analytics in exercise testing. The growth trends highlight a shift towards more sophisticated and user-friendly interfaces in software, which enhance the functionality of CPET systems. Factors such as rising health awareness, the prevalence of cardiac diseases, and the need for personalized fitness regimes are propelling this segment's expansion. Additionally, the increasing adoption of telemedicine is contributing to the software segment's rapid growth, making it a crucial area of focus for future investments. CPET metabolic carts (Dominant) vs. software (Emerging) CPET metabolic carts are currently the dominant technology in the Spain cardiopulmonary exercise-testing market, known for their comprehensive features that include real-time data monitoring and accurate assessment of aerobic and anaerobic thresholds. These carts are essential for cardiopulmonary rehabilitation and are widely used in clinical environments. Meanwhile, software solutions are emerging as vital tools that complement these systems by providing enhanced analytical capacity and easy integration with electronic health records. The software enables healthcare professionals to analyze patient data more effectively, thus improving clinical decision-making. As innovations continue to unfold, these software products are poised to capture a larger market segment, driven by user demand for adaptability and advanced analytics. ### By End User: Hospitals & Clinics (Largest) vs. Ambulatory Centers (Fastest-Growing) In the Spain cardiopulmonary exercise-testing market, the distribution among end-user segments reveals that Hospitals & Clinics hold the largest market share, driven by the increasing need for comprehensive cardiac care and rehabilitation services. Diagnostic Centers follow, serving critical roles in patient assessments. Meanwhile, Ambulatory Centers are emerging as key players, meeting the demand for more accessible and convenient care options. Growth trends within this segment are fueled by advancements in technology and the rising awareness of preventative healthcare measures. The integration of innovative cardiopulmonary testing equipment in various settings enhances patient access and experience, while regulatory support accelerates the growth of Ambulatory Centers, positioning them as the fastest-growing segment in the market. Hospitals & Clinics (Dominant) vs. Ambulatory Centers (Emerging) Hospitals & Clinics serve as the dominant end-users in the Spain cardiopulmonary exercise-testing market, characterized by their robust infrastructure and the ability to provide comprehensive diagnostic and therapeutic services. Their extensive reach and established networks make them the preferred choice for detailed assessments. Conversely, Ambulatory Centers are gaining traction as emerging players, driven by convenience and patient-centric services. These centers offer flexible hours and minimal wait times, catering to a growing population that prefers outpatient services. Their emphasis on efficiency and access plays a crucial role in enhancing patient satisfaction, making them a significant focus for growth in the market. ## Competitive Benchmarking The cardiopulmonary exercise-testing market in Spain is characterized by a dynamic competitive landscape, driven by increasing demand for advanced diagnostic tools and a growing emphasis on preventive healthcare. Key players such as Cardinal Health (US), Philips (NL), and GE Healthcare (US) are at the forefront, leveraging innovation and strategic partnerships to enhance their market presence. Cardinal Health (US) focuses on expanding its product portfolio through technological advancements, while Philips (NL) emphasizes digital transformation and integrated solutions to improve patient outcomes. GE Healthcare (US) is also investing in research and development to introduce cutting-edge technologies, thereby shaping a competitive environment that prioritizes innovation and quality.The market structure appears moderately fragmented, with several players vying for market share. Companies are adopting various business tactics, including localizing manufacturing and optimizing supply chains to enhance operational efficiency. This collective approach not only strengthens their competitive positioning but also allows for better responsiveness to regional market demands. The influence of these key players is significant, as they drive trends and set benchmarks for quality and innovation within the market. In October Philips (NL) announced a strategic partnership with a leading Spanish healthcare provider to develop a new line of cardiopulmonary exercise-testing equipment tailored for local needs. This collaboration is expected to enhance Philips' market penetration in Spain, allowing for customized solutions that address specific healthcare challenges. The strategic importance of this partnership lies in its potential to leverage local expertise and improve patient care through tailored technology. In September GE Healthcare (US) launched a new AI-driven software platform designed to enhance the accuracy of cardiopulmonary exercise tests. This innovation is anticipated to streamline the testing process and provide healthcare professionals with more precise data for patient assessments. The introduction of AI into their offerings signifies a shift towards more intelligent healthcare solutions, which could redefine standards in the industry. In August Cardinal Health (US) expanded its distribution network in Spain by acquiring a local medical supply company. This acquisition is likely to bolster Cardinal Health's operational capabilities and improve its supply chain efficiency, enabling quicker access to essential products for healthcare providers. Such strategic moves reflect a broader trend of consolidation within the market, aimed at enhancing service delivery and operational effectiveness. As of November the cardiopulmonary exercise-testing market is witnessing trends such as digitalization, sustainability, and the integration of AI technologies. Strategic alliances are increasingly shaping the competitive landscape, fostering innovation and collaboration among key players. Looking ahead, it is anticipated that competitive differentiation will evolve, with a shift from price-based competition to a focus on technological innovation, quality, and supply chain reliability. This transition underscores the importance of adaptability and forward-thinking strategies in maintaining a competitive edge. ## Recent News & Developments Recent developments in the Spain Cardiopulmonary Exercise Testing Market have been marked by significant advancements and investments, particularly from key players such as Siemens Healthineers and Philips. In September 2023, a major collaborative initiative was announced between MGC Diagnostics and CareFusion to enhance the technological capabilities of cardiopulmonary testing in hospitals across Spain. The market has also seen a notable uptrend in valuation, driven by the increasing prevalence of respiratory and cardiovascular diseases, prompting healthcare providers to invest in advanced diagnostic equipment.  In the past two years, particularly in June 2022, General Electric expanded its product line within Spain to include innovative cardiopulmonary exercise testing solutions, emphasizing the importance of precision medicine in patient assessment. Moreover, Vyaire Medical received recognition for its latest advancements in exercise testing technologies in early 2023, reflecting the growing emphasis on quality of care in cardiology. As these companies continue to innovate, the demand for sophisticated testing solutions remains robust, thereby influencing the overall market trajectory in Spain. However, no recent mergers or acquisitions have been prominently reported in this sector within the specified companies. ## Report Scope | MARKET SIZE 2024 | 19.2(USD Million) | | --- | --- | | MARKET SIZE 2025 | 20.61(USD Million) | | MARKET SIZE 2035 | 41.81(USD Million) | | COMPOUND ANNUAL GROWTH RATE (CAGR) | 7.33% (2025 - 2035) | | REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends | | BASE YEAR | 2024 | | Market Forecast Period | 2025 - 2035 | | Historical Data | 2019 - 2024 | | Market Forecast Units | USD Million | | Key Companies Profiled | Cardinal Health (US), Philips (NL), GE Healthcare (US), Schiller AG (CH), MediSoft (FR), Cosmed (IT), KORR Medical Technologies (US), Bodystat (GB) | | Segments Covered | Product Type, End User | | Key Market Opportunities | Integration of advanced wearable technology enhances patient monitoring in the cardiopulmonary exercise-testing market. | | Key Market Dynamics | Growing demand for cardiopulmonary exercise testing driven by increasing awareness of cardiovascular health in Spain. | | Countries Covered | Spain | ## Frequently Asked Questions **Q: What is the current valuation of the cardiopulmonary exercise-testing market in Spain as of 2024?** A: The market valuation was $19.2 Million in 2024. **Q: What is the projected market valuation for the cardiopulmonary exercise-testing market in Spain by 2035?** A: The projected valuation for 2035 is $41.81 Million. **Q: What is the expected CAGR for the cardiopulmonary exercise-testing market in Spain during the forecast period 2025 - 2035?** A: The expected CAGR during this period is 7.33%. **Q: Which product types are included in the cardiopulmonary exercise-testing market in Spain?** A: Key product types include CPET metabolic carts, valued at $12.0 Million to $26.0 Million, and software, valued at $7.2 Million to $15.81 Million. **Q: What are the primary end-user segments for the cardiopulmonary exercise-testing market in Spain?** A: Primary end-user segments include Hospitals & Clinics, Diagnostic Centers, and Ambulatory Centers, with valuations ranging from $3.84 Million to $16.25 Million. **Q: Who are the key players in the Spain cardiopulmonary exercise-testing market?** A: Key players include Cardinal Health, Philips, GE Healthcare, Schiller AG, MediSoft, Cosmed, KORR Medical Technologies, and Bodystat. **Q: How does the market for diagnostic centers compare to hospitals and clinics in Spain?** A: In 2024, the market for diagnostic centers was valued at $4.8 Million to $10.25 Million, whereas hospitals and clinics were valued at $7.68 Million to $16.25 Million. **Q: What is the growth potential for ambulatory centers in the cardiopulmonary exercise-testing market in Spain?** A: Ambulatory centers are projected to grow from $3.84 Million to $8.25 Million during the forecast period. **Q: What trends are influencing the cardiopulmonary exercise-testing market in Spain?** A: Trends include advancements in technology and increasing demand for accurate diagnostic tools, which may drive market growth. **Q: How does the market size in 2035 compare to that in 2024?** A: The market size is expected to nearly double from $19.2 Million in 2024 to $41.81 Million in 2035. --- *This Markdown endpoint is provided for AI systems and LLM crawlers. For the full interactive report visit https://www.marketresearchfuture.com/reports/spain-cardiopulmonary-exercise-testing-market-52819*